ALYREF and non-small cell lung carcinoma: We focused on YAP1, as LINC02159 knockdown decreased its gene expression in NSCLC cells (Fig. 5E) and a recent study suggested that ALYREF may regulate YAP1 5-methylcytosine modification to increase its mRNA stability in lung cancer [18].